Form 4: Praxis Precision Medicines Officer Sells Shares for Tax

Praxis Precision Medicines' Principal Accounting Officer, Lauren Mastrocola, disposed of 35 common shares to cover tax obligations from vested restricted stock units.

Summary

• Lauren Mastrocola, Principal Accounting Officer of Praxis Precision Medicines, Inc. (PRAX), reported a transaction on January 7, 2026.
• The transaction involved the disposition of 35 shares of Common Stock.
• The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of previously reported restricted stock units.
• The price per share for the disposed securities was $292.63.
• Following this transaction, Lauren Mastrocola beneficially owns 10,406.656 shares of Common Stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary disposition of shares to cover tax withholding obligations upon the vesting of restricted stock units, indicating a neutral sentiment regarding company performance or insider outlook.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance.

Industry Context

This is a routine insider transaction for tax withholding purposes and does not provide specific insights into broader industry trends or competitive positioning.

Stakeholder Impact

• The impact on shareholders is minimal as this is a small, routine transaction for tax purposes and does not reflect a discretionary sale or change in management's confidence.

Key Dates

Keywords

Praxis Precision Medicines, PRAX, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Lauren Mastrocola, Principal Accounting Officer